ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

UT Southwestern Simmons Cancer Center received $50 million from Simmons family.

November 4, 2005

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009